CorVel Posts 7% Revenue Growth to $959M, 20% Q4 EPS Increase
CorVel's fiscal year revenues rose 7% to $959M with EPS up 17% to $2.14, and Q4 revenues climbed 7% to $249M with EPS up 20% to $0.61. The company ended Q4 with $233M cash and repurchased $20.1M of common stock.
1. Fiscal Year 2026 Results
For the year ended March 31, 2026, CorVel generated $958.5M in revenues, a 7% increase from $895.6M a year earlier, and delivered net income of $110.3M, up 16% versus $95.2M. Diluted EPS grew 17% to $2.14 from $1.83, reflecting margin expansion and controlled operating costs.
2. Fourth Quarter Highlights
In Q4, CorVel reported $248.5M in revenues, up 7% year-over-year, with gross profit rising 9% to $63.0M at a 25% margin. Net income reached $31.0M, driving EPS of $0.61, up 20%, while the balance sheet closed with $233.1M cash and $20.1M of share repurchases.
3. Segment Performance and Strategy
CERIS, the health division, saw strong enterprise-scale prepay and post-pay platform adoption that enhances claims accuracy and revenue visibility. Meanwhile, P&C services advanced its AI-driven CareMC interface and telemedicine integrations, supporting improved efficiency, scalability and sustained margin profiles.